All Publications


  • Abstract 17013: CTX320: An Investigational in vivo CRISPR-Based Therapy Efficiently and Durably Reduces Lipoprotein (a) Levels in Non-Human Primates After a Single Dose Circulation Morrow, P. K., D'Souza, S., Pandji, J., Gowda, V., Wood, T., Lee, N., Zhang, M. L., Serwer, L., Steiger, K., Sula, E., Thorstensen, E., Urbaez, K., Usadi, J. 2023; 148